A longevity expert reveals how immune systems begin aging after 35, making people more susceptible to infections and ...
Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB silencing - ...
A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease portfolio Omeros is eligible to receive 340 million US dollars in ...
Apellis Pharmaceuticals (NASDAQ: APLS) is preparing to release its quarterly earnings on Thursday, 2025-10-30. Here's a brief overview of what investors should keep in mind before the announcement.
Livestock producers looking for a less expensive winter supplement this year should consider alfalfa for its nutritional ...
The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory ...
Still, human data is more nuanced. “While the evidence that the gut microbiome affects mood is relatively strong, evidence ...
Every day, your immune system performs a delicate balancing act, attacking harmful invaders while protecting your own tissues ...
Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...